A previous study has demonstrated that PKM2 could restraint stemness related protein Oct4 thereby triggering consequent differentiation in a glioma stem cells-derived spheroid, suggesting that PKM2 could modulate cancer cell stemness/differentiation status [50]. Here, POU5F1 is linked to central nervous system cancer.